Blog

■ A review of the Alcohol Use Disorders Identification Test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: past issues and future directions

J C Higgins-Biddle, T F Babor

Am J Drug Alcohol Abuse 2018, vol 44 (6): 578-586

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217805/

 

■ O padrão de consume de álcool é alterado após a cirurgia bariátrica? Uma revisão integrativa

Gregorio, Valeria Duarte et al

ABCD, arq. bras. cir. dig., 2018, vol.31, no.2

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202018000200509&lng=pt&nrm=iso&tlng=pt (portuguese)

 

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202018000200509&lng=pt&nrm=iso&tlng=en (english)

 

■ Medications for alcohol use disorder: an overview

Mohammed Akbar, Mark Egli, Young-Eun Cho et al

Pharmacol Ther. 2018 May; 185: 64–85

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898984/

 

■ Medications for alcohol use disorder

B T Winslow, M Onysko, M Hebert

Am Fam Physician 2016, vol 93 (6): 457-465

http://www.aafp.org/afp/2016/0315/p457.html

 

■ Nutritional status during inpatient alcohol detoxification

Marie-Astrid Gautron, F Questel, M Lejoyeux et al

Alcohol and Alcoholism 2018, vol 53 (1) 64–70,

https://academic.oup.com/alcalc/article/53/1/64/4608042

 

■ The effect of brief interventions for alcohol among people mental health conditions: a systematic review of randomized trials and narrative synthesis

S Boniface, I Malet-Lambert, R Coleman et al

Alcohol and Alcoholism 2018, vol 53 (5): 282-293

https://academic.oup.com/alcalc/article/53/3/282/4774988

 

■ Effectiveness of mass media campaigns to reduce alcohol consumption and harm: a systematic review

B Young, S Lewis, S V Katikireddi et a

Alcohol and Alcoholism 2018, vol 53 (3): 302-316

https://academic.oup.com/alcalc/article/53/3/302/4796878

 

■ Changing collective social norms in favours of reduced harmful use of alcohol: a review of reviews

P Anderson, E Jané-Llopis, O S M Hasan, J Rehm

Alcohol and Alcoholism 2018, vol 53 (3): 326-332

https://academic.oup.com/alcalc/article/53/3/326/4810743

 

■ Instruments for the Evaluation of Alcohol Use in Indigenous Communities – A Systematic Review

Souza, Ronaldo Santhiago Bonfim de et al.

Trends Psychol., Sept 2018, vol.26, no.3, p.1589-1603

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2358-18832018000301589&lng=pt&nrm=iso&tlng=en

 

■ Alcohol and the risk of pneumonia: a systematic review and meta-analysis

E Simou, J Britton, J Leonardi-Bee

BMJ Open 2018, vol 8 (8)

https://bmjopen.bmj.com/content/8/8/e022344

 

■ Executive functions, memory, and social cognitive deficits and recovery in chronic alcoholism: a critical review to inform future research

Anne-Pascale Le Berre, Rosemary Fama, Edith V. Sullivan

Alcohol Clin Exp Res. 2017 Aug; 41(8): 1432–1443

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531758/

 

■ Exercise as treatment for alcohol use disorders: systematic review and meta-analysis

M Hallgren, D Vancampfort, E S Giesen et al

British Journal of Sports Medicine 2017, vol 51 (4)

http://bjsm.bmj.com/content/51/14/1058

 

■ Association between alcohol sports sponsorship and consumption: a systematic review

K Brown

Alcohol and Alcoholism 2016, vol 51 (6): 747-755

https://academic.oup.com/alcalc/article/51/6/747/2374095/Association-Between-Alcohol-Sports-Sponsorship-and

 

■ Sex differences in the behavioral sequelae of chronic ethanol exposure

Nicholas J. Jury, Jeffrey F. DiBerto, Thomas L. Kash, Andrew Holmes

Alcohol. 2017 Feb; 58: 53–60.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253321/

 

■ Long-term alcohol use patterns and HIV disease severity

Brandon D.L. Marshall, Janet P. Tate, Kathleen A. McGinnis et al

AIDS. 2017 Jun 1; 31(9): 1313–1321

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596310/

 

■ Treatment of alcohol use disorder in patients with alcoholic liver disease

Lorenzo Leggio, Mary R. Lee

Am J Med. 2017 Feb; 130(2): 124–13

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263063/

 

■ Reduced drinking in alcohol dependence treatment, what is the evidence

K Mann, H –J Aubin, K Witkiewitz

Eur Addict Res 2017, vol 23: 219-230

https://www.karger.com/Article/FullText/481348

 

■ Influence of stress associated with chronic alcohol exposure on drinking

Howard C. Becker

Neuropharmacology. 2017 Aug 1; 122: 115–126

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497303/

 

■ Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalinnk study

A Thompson, D M Aschcroft, L Owens et al

PLoS ONE2017, vol 12 (3)

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0173272

 

■ Long-term alcohol consumption and breast, upper aero-digestive tract and colorectal cancer risk: a systematic risk review and meta-analysis

H Jayasekara, R J MacInnis, R Room, D R English

Alcohol and Alcoholism 2016, vol 51 (3): 315-330

https://academic.oup.com/alcalc/article/51/3/315/2888170/Long-Term-Alcohol-Consumption-and-Breast-Upper

 

■ Reductions in alcohol craving following naltrexone treatment for heavy drinking

A W Helstrom, F C Blow, V Saymaker et al

Alcohol and Alcoholism 2016, vol 51 (5): 562-566

https://academic.oup.com/alcalc/article/51/5/562/1740449/Reductions-in-Alcohol-Craving-Following-Naltrexone

 

■ Does industry-driven alcohol marketing influence adolescent drinking behavior? A systematic review

S Scott, C Muirhead, J Schucksmith et al

Alcohol and Alcoholism 2016, vol 51 (1): 84-94

https://academic.oup.com/alcalc/article/52/1/84/2614654/Does-Industry-Driven-Alcohol-Marketing-Influence

 

■ A meta-analysis of theory of mind in alcohol use disorders

R C Onuoha, D S Quintana, M Lyyers, A J Guastella

Alcohol and Alcoholism 2016, vol 51 (4): 410-415

https://academic.oup.com/alcalc/article/51/4/410/1740697/A-Meta-analysis-of-Theory-of-Mind-in-Alcohol-Use

 

■ Consumo de álcool e condições de trabalho: uma revisão integrativa

G A S Costa, T H da Silva, A M Silveira

Rev Med Minas Gerais 2016, vol 26 (Supl 8): S118-S122

http://rmmg.org/artigo/detalhes/2134

 

■ Treatment of alcohol-induced psychotic disorder (alcoholic hallucinosis) – a systematic review

B Masood, P Lepping, D Romanov

Alcohol and Alcoholism 2016, vol 51 (5): 84-92

https://academic.oup.com/alcalc/article/53/3/259/4627701

 

■ Overview of the genetic of alcohol use disorder

E A Tawa, S D Hall, F W Lohff

Alcohol and Alcoholism 2016, vol 51 (5): 507-514

https://academic.oup.com/alcalc/article/51/5/507/2237006/Overview-of-the-Genetics-of-Alcohol-Use-Disorder

 

■ Measuring alcohol consumption in population surveys: a review of international guidelines and comparison with survey in England

M D Nugawela, T Langley, L Szatkowski, S Lewis

Alcohol and Alcoholism 2016, vol 51 (5): 84-92

https://academic.oup.com/alcalc/article/51/1/84/2888167/Measuring-Alcohol-Consumption-in-Population

 

■ Alcohol and atrial fibrillation

A Voskoboinik, S Prabhu, L Ling et al

JACC 2016, vol 68 (23)

http://www.onlinejacc.org/content/68/23/2567

 

■ The prevalence of metabolic syndrome in alcohol use disorders: a systematic review and meta-analysis

D Vancampfort, M Hallgren, J Mugisha et al

Alcohol and Alcoholism 2016, vol 51 (5): 515-521

https://academic.oup.com/alcalc/article/51/5/515/1740510/The-Prevalence-of-Metabolic-Syndrome-in-Alcohol

 

■ Alcohol use disorder in primary health care: What do we know and where do we go?

J Rehm, P Anderson, J Manthey et al

Alcohol and Alcoholism 2016, vol 51 (5): 412-427

https://academic.oup.com/alcalc/article/51/4/422/1739927/Alcohol-Use-Disorders-in-Primary-Health-Care-What

 

■ Biomarker-based approaches for assessing alcohol use disorders

Onni Niemelä

Int J Environ Res Public Health. 2016 Feb; 13(2): 16

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772186/

 

■ STREAM: Elucidanting how alcohol use disorders are managed in UK general practice today

F Coste, N Rahhai, P Wallace

Alcohol and Alcoholism 2016, vol 51 (4): 428-435

https://academic.oup.com/alcalc/article/51/4/428/1740834/STREAM-Elucidating-How-Alcohol-Use-Disorders-are

 

■ Alcohol marketing on twitter and Instagram: evidence of directly advertising to youth/adolescents

A E Barry, A M Bates, O Olusanya et al

Alcohol and Alcoholism 2016, vol 51 (4): 487-492

https://academic.oup.com/alcalc/article/51/4/487/1739960/Alcohol-Marketing-on-Twitter-and-Instagram

 

■ Fetal alcohol spectrum disorders: What pediatric providers need to know

A Nash, L Nash

Journal of Pediatric Health Care2017, vol 31(5): 594-606

https://www.jpedhc.org/article/S0891-5245(17)30072-X/fulltext

 

■ Alcohol use disorders in pregnancy

Jeffrey DeVido, Olivera Bogunovic, Roger D. Weiss

Harv Rev Psychiatry. 2015 Mar-Apr; 23(2): 112–121

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530607/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Novo endereço:

Consultório: Rua Padre Rolim 815/sala 815

Tel: 33245518 (Consulta Particular/Unimed)

 

– Centro Médico Unimed BH/Contagem/Pedro I

Belo Horizonte/MG/Brasil

CRMMG: 7026

Email: pfleite1873@gmail.com

■ Cannabidiol (CBD) for schizophrenia: promise or pipe dream?

J M Pierre

Current Psychiatry 2019: vol 18 (5): 12-16

https://www.mdedge.com/psychiatry/article/199443/schizophrenia-other-psychotic-disorders/cannabidiol-cbd-schizophrenia

 

■ Medicinal use of cannabis based products and cannabinoids

T P Freeman, C Hindocha, S F Green, M A P Bloomfield

BMJ 2019, vol 365: l1141

https://www.bmj.com/content/365/bmj.l1141

 

■ Digital technology for internet access by patients with early-stage schizophrenia in Spain: Multicenter Research Study

P Fernández-Sotos, A Fernandez-Caballero, P González et al

Journal of Medical Internet Research 2019, vol 21 (4)

https://www.jmir.org/2019/4/e11824/

 

■ Treatment-resistant schizophrenia: genetic and neuroimaging

Vita A, Minelli A, Barlati S, Deste G, Giacopuzzi E, Valsecchi P, Turrina C, Gennarelli M.

Front Pharmacol. 2019 Apr 16;10:402

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476957/

 

■ Overcoming barrier to effective management of tardive dyskinesia

Caroff SN.

Neuropsychiatr Dis Treat. 2019 Apr 4;15:785-794

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459148/

 

■ Trends in the scientific literatures on atypical antipsychotic drugs in the United Kingdom: a bibliometric study

Francisco López-Muñoz, Derek K. Tracy, F. Javier Povedano-Montero et al

Ther Adv Psychopharmacol. 2019; 9: 204512531882020

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378637/

 

■ Restarting antidepressant and antipsychotic medication after intentional overdoses: need for evidence-based guidance

Emma Tay, Andreas Sotiriou, Garry G. Graham et al

Ther Adv Psychopharmacol. 2019; 9: 204512531983688

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444415/

 

■ Autistic symptoms in schizophrenia spectrum disorders: a systematic review and meta-analysis

De Crescenzo F, Postorino V, Siracusano M, Riccioni A, Armando M, Curatolo P, Mazzone L.

Front Psychiatry. 2019 Feb 21;10:78

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393379/

 

■ Childhood trauma in schizophrenia: current findings and research perspectives

Popovic D, Schmitt A, Kaurani L, Senner F, Papiol S, Malchow B, Fischer A, Schulze TG, Koutsouleris N, Falkai P.

Front Neurosci. 2019 Mar 21;13:274

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448042/

 

■ Barrier to using clozapine in treatment-resistant schizophrenia: systematic review

Saeed Farooq, Abid Choudry, Dan Cohen, Farooq Naeem, Muhammad Ayub

BJPsych Bull. 2019 Feb; 43(1): 8–16

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327301/

 

■ Role of paliperidone palmite 3-monthly in the management of schizophrenia: insights from clinical practice

Alicia Lopez, Jose Rey

Neuropsychiatr Dis Treat. 2019; 15: 449–456

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375110/

 

■ Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy

Kristen Ward, Leslie Citrome

Neuropsychiatr Dis Treat. 2019; 15: 247–257

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339638/

 

■ Peripheral biomarkers for first-episode psychosis – opportunities from the neuroinflammatory hypothesis of schizophrenia

Nuno Trovão, Joana Prata, Orlando VonDoellinger, Susana Santos, Mário Barbosa, Rui Coelho

Psychiatry Investig. 2019 Mar; 16(3): 177–184

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444098/

 

■ Personalizing antipsychotic treatment: evidence and throughts on individualized tailoring of antipsychotic dosage in the treatment of psychotic disorders

Lex Wunderink

Ther Adv Psychopharmacol. 2019; 9: 2045125319836566

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457023/

 

■ Emotinal intelligence and schizophrenia spectrum disorders: a critical review

Martins, Fernanda de Marzio Pestana et al.

Trends Psychiatry Psychother., Mar 2019, vol.41, no.1, p.94-102

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2237-60892019000100013&lng=en&nrm=iso&tlng=en

 

■ Schizophrenia: What non-psychiatrists physicians need to know?

T Queirós, F Coelho, L Linhares, D Telles-Correia

Acta Med Port 2019, vol 32 (1): 70-77

https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10768/5592

 

■ Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews

S Ijaz, B Bolea, S Davies et al

BMC Psychiatry 2018, vol 18: 275

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122457/

 

■ Women who suffer from schizophrenia: critical issues

M V Seeman

World J Psychiatry 2018, vol 8 (5): 125-136

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230925/

 

■ The acute efficacy of antipsychotic in schizophrenia: a review of recent meta-analysis

P M Haddad, C U Correl

Ther Adv Psychopharmacol 2018, vol 8 (11): 303-318

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180374/

 

■ Are structural brain changes in schizophrenia related to antipsychotic medication? A narrative review of the evidence from a clinical perspective

S M Lawrie,

Ther Adv Psychopharmacol 2018, vol 8 (11): 319-326

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180375/

 

■ Schizotypy, schizotypic psychopathology and schizophrenia

M F Lenzenweger,

World Psychiatry 2018, vol 17 (1): 25-26

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775125/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Novo endereço:

Consultório: Rua Padre Rolim 815/sala 815

Tel: 33245518 (Consulta Particular/Unimed)

 

– Centro Médico Unimed BH/Contagem/Pedro I

Belo Horizonte/MG/Brasil

CRMMG: 7026

Email: pfleite1873@gmail.com